patients receiving combination OAD therapy were receiving metformin as part of their therapy. Data are presented for the ITT population; missingpostbaseline efficacy data were imputed using LOCF approach. OAD, Oral antidiabetic.1306 Blevins et al. Better Glycemic Control with Exenatide Once Weekly J Clin Endocrinol Metab, May 2011, 96(5):1301â€“1310 The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 13 May 2015. at 07:22 For personal use only. No other uses without permission. . All rights reserved.